Search Results - "MAMANE, Yael"
-
1
eIF4E - from translation to transformation
Published in Oncogene (19-04-2004)“…Over the years, studies have focused on the transcriptional regulation of oncogenesis. More recently, a growing emphasis has been placed on translational…”
Get full text
Journal Article -
2
Multiple Regulatory Domains Control IRF-7 Activity in Response to Virus Infection
Published in The Journal of biological chemistry (03-11-2000)“…Recent studies implicate the interferon regulatory factors (IRF), IRF-3 and IRF-7, as key activators of Type 1 interferon genes, as well as the RANTES…”
Get full text
Journal Article -
3
Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target
Published in Molecular cancer therapeutics (01-04-2009)“…Connexin43 ( Cx43 ) is often deregulated in breast cancer tissue compared with normal adjacent tissue. Stable reexpression of Cx43 in cancer slows growth and…”
Get full text
Journal Article -
4
Structural and Functional Analysis of Interferon Regulatory Factor 3: Localization of the Transactivation and Autoinhibitory Domains
Published in Molecular and Cellular Biology (01-04-1999)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
5
Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y
Published in Bioorganic & medicinal chemistry letters (15-07-2011)“…Our series of competitive antagonists against the G-protein coupled receptor P2Y₁₄ were found to be highly shifted in the presence of serum (>99% protein…”
Get full text
Journal Article -
6
HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators
Published in Oncogene (15-02-2001)“…Human herpes virus 8 (HHV-8) has developed unique mechanisms for altering cellular proliferative and apoptotic control pathways by incorporating viral homologs…”
Get full text
Journal Article -
7
The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14
Published in Bioorganic & medicinal chemistry letters (15-05-2011)“…A weak, UDP-competitive antagonist of the pyrimidinergic receptor P2RY(14) with a naphthoic acid core was identified through high-throughput screening…”
Get full text
Journal Article -
8
Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines
Published in Oncogene (20-02-2003)“…Primary effusion lymphoma (PEL) is a lymphoproliferative disease of B-cell origin that is associated with HHV-8 infection. PEL cells harbor a non-B, non-T…”
Get full text
Journal Article -
9
The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activation
Published in Diabetes (New York, N.Y.) (01-09-2009)“…The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activation Yaël…”
Get full text
Journal Article -
10
Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation
Published in PloS one (21-02-2007)“…Translation deregulation is an important mechanism that causes aberrant cell growth, proliferation and survival. eIF4E, the mRNA 5' cap-binding protein, plays…”
Get full text
Journal Article -
11
When translation arises from its TORpor
Published in M.S. Médecine sciences (01-05-2006)“…Gene regulation by transcriptional and post-translational mechanisms is implicated in the regulation of cellular homeostasis. Transcriptional deregulation has…”
Get more information
Journal Article -
12
p53-Dependent Translational Control of Senescence and Transformation via 4E-BPs
Published in Cancer cell (06-11-2009)“…eIF4E, the mRNA 5′ cap-binding translation initiation factor, is overexpressed in numerous cancers and is implicated in mechanisms underlying oncogenesis and…”
Get full text
Journal Article -
13
CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition
Published in Nature (London) (28-04-2022)“…Amplification of the CCNE1 locus on chromosome 19q12 is prevalent in multiple tumour types, particularly in high-grade serous ovarian cancer, uterine tumours…”
Get full text
Journal Article -
14
RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
Published in Molecular cancer therapeutics (01-02-2022)“…Ataxia telangiectasia and Rad3-related (ATR) kinase protects genome integrity during DNA replication. RP-3500 is a novel, orally bioavailable clinical-stage…”
Get full text
Journal Article -
15
Selective DNA Binding and Association with the CREB Binding Protein Coactivator Contribute to Differential Activation of Alpha/Beta Interferon Genes by Interferon Regulatory Factors 3 and 7
Published in Molecular and Cellular Biology (01-09-2000)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
16
identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y
Published in Bioorganic & medicinal chemistry letters (15-05-2011)“…A weak, UDP-competitive antagonist of the pyrimidinergic receptor P2RY₁₄ with a naphthoic acid core was identified through high-throughput screening…”
Get full text
Journal Article -
17
Identification of RP-6685, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ
Published in Journal of medicinal chemistry (13-10-2022)“…DNA polymerase theta (Polθ) is an attractive synthetic lethal target for drug discovery, predicted to be efficacious against breast and ovarian cancers…”
Get full text
Journal Article -
18
Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306
Published in Journal of medicinal chemistry (11-08-2022)“…PKMYT1 is a regulator of CDK1 phosphorylation and is a compelling therapeutic target for the treatment of certain types of DNA damage response cancers due to…”
Get full text
Journal Article -
19
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)
Published in Journal of medicinal chemistry (22-02-2024)“…ATR is a key kinase in the DNA-damage response (DDR) that is synthetic lethal with several other DDR proteins, making it an attractive target for the treatment…”
Get full text
Journal Article -
20
Abstract P054: RP-3500: A novel, potent and selective ATR inhibitor that is effective in pre-clinical models as a monotherapy and in combination with PARP inhibitors
Published in Molecular cancer therapeutics (01-12-2021)“…Abstract Background: Ataxia telangiectasia and Rad3-related (ATR) protein kinase is a key mediator of cellular DNA damage repair (DDR) and is activated in…”
Get full text
Journal Article